AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Claritas Pharmaceuticals, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0 - $0
Market Cap
3.66K
AVG Volume
231
Trailing/Forward PE
0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-30
Primary Exchange
Other OTCUS
Revenue (USD)
00.250.50.75119 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Revenue (USD) by quarter
PeriodRevenue (USD)
21 Q30
21 Q20
21 Q10
20 Q40
20 Q30
20 Q20
20 Q10
19 Q40
19 Q30
19 Q20
Net Income (USD)
-10M010M20M19 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Net Income (USD) by quarter
PeriodNet Income (USD)
21 Q3181K
21 Q2-1.94M
21 Q1-2.3M
20 Q4-654K
20 Q3-413K
20 Q2-8.67M
20 Q113.94M
19 Q4-8.48M
19 Q3-976K
19 Q2-5.36M
Operating Income (USD)
-4M-2M02M19 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Operating Income (USD) by quarter
PeriodOperating Income (USD)
21 Q3-514K
21 Q2-549K
21 Q1-159K
20 Q41.99M
20 Q3-822K
20 Q2-368K
20 Q1-555K
19 Q4-536K
19 Q3-2.18M
19 Q2-3.14M
EBITDA (USD)
-20M-10M010M20M19 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF EBITDA (USD) by quarter
PeriodEBITDA (USD)
21 Q3695K
21 Q20
21 Q1-2.72M
20 Q4-618K
20 Q31.03M
20 Q20
20 Q113.98M
19 Q4-7.71M
19 Q31.73M
19 Q2-10.43M
Cash Flows (USD)
-6M-4M-2M02M19 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Cash Flows (USD) by quarter
PeriodCash Flows (USD)
21 Q3-281K
21 Q2136K
21 Q1-324K
20 Q4-484K
20 Q3267K
20 Q2-66K
20 Q1-26K
19 Q4-155K
19 Q3-1.11M
19 Q2-4.38M
EPS (USD)
-0.5-0.2500.250.50.7519 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF EPS (USD) by quarter
PeriodEPS (USD)
21 Q30.01
21 Q2-0.06
21 Q1-0.08
20 Q4-0.02
20 Q3-0.02
20 Q2-0.33
20 Q10.6
19 Q4-0.35
19 Q3-0.04
19 Q2-0.24
Expenses (USD)
-4M-2M02M4MR&DSG&ACapex19 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Expenses (USD) by quarter
PeriodExpenses (USD)
21 Q3514K
21 Q2549K
21 Q1159K
20 Q4-1.99M
20 Q3836K
20 Q2442K
20 Q1555K
19 Q4536K
19 Q32.18M
19 Q23.14M
Cash & Debt (USD)
0500K1M1.5MCashLong Term DebtShort Term Debt19 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
21 Q32K
21 Q2282K
21 Q128K
20 Q45K
20 Q3490K
20 Q211K
20 Q13K
19 Q432K
19 Q331K
19 Q2822K
Debt ratios
-0.6-0.4-0.2-00.219 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Debt ratios by quarter
PeriodDebt ratios
21 Q3-0.21
21 Q2-0.41
21 Q1-0.16
20 Q40.06
20 Q30.06
20 Q20.1
20 Q1-0.28
19 Q4-0.04
19 Q3-0.11
19 Q20.02
Margins
0%50%100%150%12 Q112 Q212 Q312 Q413 Q113 Q213 Q313 Q414 Q114 Q4
CLAZF Margins by quarter
PeriodMargins
14 Q4100%
14 Q1100%
13 Q4100%
13 Q3100%
13 Q2100%
13 Q1100%
12 Q4100%
12 Q3100%
12 Q2100%
12 Q1100%
Return on Capital
-1500%-1000%-500%0%500%19 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Return on Capital by quarter
PeriodReturn on Capital
21 Q35.52%
21 Q2-70.38%
21 Q1-1307.39%
20 Q4-43.4%
20 Q3-18.23%
20 Q2-352.42%
20 Q1126.96%
19 Q4246.84%
19 Q3-20.65%
19 Q2-101.61%
Shares Outstanding
010M20M30M40M19 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Shares Outstanding by quarter
PeriodShares Outstanding
21 Q335.41M
21 Q233.41M
21 Q127.53M
20 Q427.11M
20 Q327.08M
20 Q226.27M
20 Q126.07M
19 Q424.25M
19 Q325.07M
19 Q222.34M
Book Value Per Share (USD)
-0.200.20.40.619 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
21 Q30.09
21 Q20.08
21 Q10.01
20 Q40.06
20 Q30.08
20 Q20.09
20 Q10.42
19 Q4-0.14
19 Q30.19
19 Q20.24
Total Assets (USD)
010M20M30M40M19 Q219 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q3
CLAZF Total Assets (USD) by quarter
PeriodTotal Assets (USD)
21 Q311.02M
21 Q211.15M
21 Q18.11M
20 Q410.45M
20 Q310.88M
20 Q213.09M
20 Q125.16M
19 Q425.25M
19 Q336.44M
19 Q235.23M
PE Ratio
00.050.10.150.2med 0.1Apr 19May 19Jul 19Aug 19Apr 21May 21Jun 21
CLAZF PE Ratio by quarter
PeriodPE Ratio
Jun 210.07
Jun 210.08
Jun 210.09
Jun 210.11
May 210.12
May 210.11
May 210.1
May 210.09
Apr 210.11
Apr 210.12
Apr 210.16
Apr 210.11
Apr 210.13
Sep 190.1
Sep 190.1
Sep 190.11
Sep 190.11
Aug 190.12
Aug 190.12
Aug 190.1
Aug 190.11
Aug 190.1
Jul 190.1
Jul 190.11
Jul 190.09
Jul 190.11
Jun 190.03
Jun 190.03
Jun 190.03
Jun 190.03
May 190.03
May 190.03
May 190.02
May 190.02
May 190.02
Apr 190.02
Apr 190.03
Apr 190.03
Apr 190.03
Free Cash Flow Yield
-3000000%-2000000%-1000000%0%med -26912.54%Sep 24May 25Sep 25Jan 26May 26Sep 26
CLAZF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-26912.54%
Sep 26-26912.54%
Aug 26-26912.54%
Aug 26-26912.54%
Aug 26-26912.54%
Aug 26-26912.54%
Jul 26-26912.54%
Jul 26-26912.54%
Jul 26-26912.54%
Jul 26-26912.54%
Jul 26-26912.54%
Jun 26-26912.54%
Jun 26-26912.54%
Jun 26-26912.54%
Jun 26-26912.54%
May 26-26912.54%
May 26-26912.54%
May 26-26912.54%
May 26-26912.54%
May 26-26912.54%
Apr 26-26912.54%
Apr 26-26912.54%
Apr 26-26912.54%
Apr 26-26912.54%
Mar 26-26912.54%
Mar 26-26912.54%
Mar 26-26912.54%
Mar 26-26912.54%
Feb 26-2691254.13%
Feb 26-26912.54%
Feb 26-26912.54%
Feb 26-26912.54%
Jan 26-26912.54%
Jan 26-26912.54%
Jan 26-26912.54%
Jan 26-26912.54%
Jan 26-26912.54%
Dec 25-26912.54%
Dec 25-26912.54%
Dec 25-26912.54%
Dec 25-26912.54%
Nov 25-26912.54%
Nov 25-26912.54%
Nov 25-26912.54%
Nov 25-26912.54%
Oct 25-26912.54%
Oct 25-26912.54%
Oct 25-26912.54%
Oct 25-26912.54%
Oct 25-26912.54%
Sep 25-26912.54%
Sep 25-26912.54%
Sep 25-26912.54%
Sep 25-26912.54%
Aug 25-26912.54%
Aug 25-26912.54%
Aug 25-26912.54%
Aug 25-26912.54%
Aug 25-26912.54%
Jul 25-26912.54%
Jul 25-26912.54%
Jul 25-26912.54%
Jul 25-26912.54%
Jun 25-26912.54%
Jun 25-26912.54%
Jun 25-26912.54%
Jun 25-26912.54%
May 25-26912.54%
May 25-26912.54%
Jan 25-26912.54%
Jan 25-26912.54%
Jan 25-26912.54%
Jan 25-26912.54%
Dec 24-26912.54%
Dec 24-2691254.13%
Dec 24-26912.54%
Dec 24-26912.54%
Nov 24-26912.54%
Nov 24-26912.54%
Nov 24-269125.41%
Nov 24-26912.54%
Nov 24-26912.54%
Oct 24-2691254.13%
Sep 24-26912.54%
Sep 24-26912.54%
Sep 24-26912.54%
Sep 24-26912.54%
Aug 24-26912.54%
Aug 24-26912.54%
Aug 24-26912.54%
Aug 24-26912.54%
Aug 24-26912.54%
Jul 24-26912.54%
Jun 24-26912.54%
May 24-26912.54%
Apr 24-26912.54%
Feb 24-269125.41%
Feb 24-269125.41%
Jan 24-269125.41%
Jan 24-26912.54%
EV/EBITDA
0.050.080.10.120.15med 0.1Apr 19Jun 19Nov 20Jan 21Mar 21Apr 21Jun 21
CLAZF EV/EBITDA by quarter
PeriodEV/EBITDA
Jun 210.08
Jun 210.09
Jun 210.09
Jun 210.09
May 210.1
May 210.1
May 210.09
May 210.09
Apr 210.1
Apr 210.1
Apr 210.11
Apr 210.1
Apr 210.1
Mar 210.12
Mar 210.13
Mar 210.13
Mar 210.12
Feb 210.14
Feb 210.1
Feb 210.1
Feb 210.1
Jan 210.06
Jan 210.06
Jan 210.06
Jan 210.06
Dec 200.06
Dec 200.12
Dec 200.1
Dec 200.1
Dec 200.1
Nov 200.1
Nov 200.1
Nov 200.1
Nov 200.1
Oct 200.1
Oct 200.1
Oct 200.1
Oct 200.1
Oct 200.1
Jun 190.07
Jun 190.06
Jun 190.07
Jun 190.06
May 190.07
May 190.06
May 190.06
May 190.05
May 190.05
Apr 190.06
Apr 190.07
Apr 190.08
Apr 190.08
Price/Operating Cashflow
010203040med 16.93Dec 20Jan 21Jan 21Feb 21Feb 21Mar 21Mar 21
CLAZF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 2123.7
Mar 2127.02
Mar 2126.75
Mar 2124.38
Feb 2130.47
Feb 2117.13
Feb 2116.93
Feb 2114.9
Jan 210.68
Jan 210.68
Jan 210.68
Jan 210.68
Dec 200.68
Price to Book
0000med 0Aug 24Dec 24Jul 25Oct 25Feb 26May 26Sep 26
CLAZF Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Sep 240
Sep 240
Sep 240
Sep 240
Aug 240
Aug 240
Aug 240
Aug 240
Aug 240
Jul 240
Jun 240
May 240
Apr 240
Feb 240
Feb 240
Jan 240
Jan 240
Claritas Pharmaceuticals, Inc.
CLAZF
Stockpicker

Video analysis: CLAZF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.